Physician profile
Michael S Smith
NPI 1003918855
$726.60
in general payments reported to CMS, 2019-2025
19 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.88 · 2022: $158 · 2023: $161 · 2024: $193 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $130.32 | 2021-2025 | Gelsyn-3, Durolane, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $102.14 | 2022-2025 | Euflexxa |
| Si-Bone, INC. | $68.66 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $48.47 | 2024-2025 | |
| Kerecis Limited | $45.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $40.68 | 2023 | Pico, Stravix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.25 | 2021-2023 | Ofev |
| Paragon 28, INC. | $35.94 | 2022 | |
| Averitas Pharma INC. | $33.44 | 2024 | Qutenza |
| Abbvie INC. | $23.24 | 2023 | |
| Mylan Specialty L.P. | $21.50 | 2024 | Yupelri |
| Fidia Pharma USA INC. | $19.52 | 2022 | |
| Kci USA, INC. | $18.93 | 2023 | Prevena |
| Mimedx Group, INC. | $18.71 | 2025 | |
| Treace Medical Concepts, INC. | $17.63 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $17.17 | 2022 | |
| Sonex Health, INC. | $17.15 | 2025 | Sx-One Microknife |
| Sanofi-Aventis U.S. LLC | $15.84 | 2021 | |
| Depuy Synthes Sales INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.